Merck Locates Frozen Batch of Undisclosed Ebola Vaccine, Will Donate for Testing in Uganda’s Outbreak

October 24, 2022

(Science) – In a revelation that may help Uganda combat its outbreak of Ebola, the pharmaceutical giant Merck has acknowledged to Science—after repeated inquiries—that it has up to 100,000 doses of an experimental vaccine for the deadly viral disease in its freezers in Pennsylvania and will donate them. The World Health Organization (WHO) and the Ugandan government are discussing whether and how these doses can be incorporated into one or more clinical trials of other candidate Ebola vaccines that could launch as soon as next month. (Read More)